Atypical fibroxanthoma: A review of the literature

Dermatologic Surgery

Volumn 37, Issue 2, 2011, Pages 146-157

  Iorizzo III, Luciano J ^a   Brown, Marc D ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL FIBROXANTHOMA; BASAL CELL CARCINOMA; CANCER RECURRENCE; CANCER SURGERY; CHEMOSURGERY; DESMOPLASTIC MELANOMA; DIFFERENTIAL DIAGNOSIS; FIBROXANTHOMA; FOLLOW UP; GERIATRIC PATIENT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MEDICAL LITERATURE; MEDLINE; MELANOMA; MERKEL CELL TUMOR; PATHOGENESIS; PLEOMORPHIC SARCOMA; PRIORITY JOURNAL; PROGNOSIS; PYOGENIC GRANULOMA; RADIATION INJURY; REVIEW; RISK ASSESSMENT; SARCOMA; SKIN CANCER; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; ULTRAVIOLET RADIATION;

GRANULOMA; HUMANS; SKIN DISEASES; XANTHOMATOSIS;

EID: 79951947092     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2010.01843.x     Document Type: Review

References (123)

1. Helwig EB., Atypical fibroxanthoma, in tumor seminar: proceedings of 18th annual seminar of San Antonio society of pathologists, 1961. Tex J Med 1963; 59: 664-7.
2. Alguacil-Garcia A, Unni KK, Goellner JR, Winkelmann RK., Atypical fibroxanthoma of the skin: an ultrastructural study of two cases. Cancer 1977; 40: 1471-80.
3. Lesica A, Harwood TR, Yokoo H., Atypical fibroxanthoma of ethmoid sinus. Arch Otolaryngol 1975; 101: 506-8.
4. Hudson AW, Winkelmann RK., Atypical fibroxanthoma of the skin: a reappraisal of 19 cases in which the original diagnosis was spindle-cell squamous carcinoma. Cancer 1972; 29: 413-22.
5. Starink TH, Hausman R, Van Delden L, Neering H., Atypical fibroxanthoma of the skin. presentation of 5 cases and a review of the literature. Br J Dermatol 1977; 97: 167-77.
6. Skoulas IG, Price M, Andrew JE, Kountakis SE., Recurrent atypical fibroxanthoma of the cheek. Am J Otolaryngol 2001; 22: 73-5. (Pubitemid 32156420)
7. Weiss SW, Goldblum JR., Malignant fibrous histiocytoma (pleomorphic undifferentiated sarcoma). In: Enzinger & Weiss's soft tissue tumors. 5th edition. Mosby: Elsevier; 2008. p. 403-27.
8. Fretzin DF, Helwig EB., Atypical fibroxanthoma of the skin. A clinicopathologic study of 140 cases. Cancer 1973; 31: 1541-52.
9. Mirza B, Weedon D., Atypical fibroxanthoma: a clinicopathological study of 89 cases. Australas J Dermatol 2005; 46: 235-8.
10. Kemp JD, Stenn KS, Arons M, Fischer J., Metastasizing atypical fibroxanthoma. coexistence with chronic lymphocytic leukemia. Arch Dermatol 1978; 114: 1533-5. (Pubitemid 9032018)
11. Cooper JZ, Newman SR, Scott GA, Brown MD., Metastasizing atypical fibroxanthoma (cutaneous malignant histiocytoma): report of five cases. Dermatol Surg 2005; 31: 221, 5; discussion 225.
12. Helwig EB, May D., Atypical fibroxanthoma of the skin with metastasis. Cancer 1986; 57: 368-76. (Pubitemid 16212045)
13. Fletcher C, Unni K, Mertens F., World Health Organization classification of tumors: pathology and genetics of tumors of soft tissue and bone. Lyon, France: IARC Press; 2002.
14. Stadler FJ, Scott GA, Brown MD., Malignant fibrous tumors. Semin Cutan Med Surg 1998; 17: 141-52.
15. Anderson HL, Joseph AK., A pilot feasibility study of a rare skin tumor database. Dermatol Surg 2007; 33: 693-6. (Pubitemid 46855047)
16. Ang GC, Roenigk RK, Otley CC, et al,. More than 2 decades of treating atypical fibroxanthoma at Mayo Clinic: what have we learned from 91 patients? Dermatol Surg 2009; 35: 765-72.
17. Luzar B, Calonje E., Morphological and immunohistochemical characteristics of atypical fibroxanthoma with a special emphasis on potential diagnostic pitfalls: a review. J Cutan Pathol 2010; 37: 301-9.
18. Huether MJ, Zitelli JA, Brodland DG., Mohs micrographic surgery for the treatment of spindle cell tumors of the skin. J Am Acad Dermatol 2001; 44: 656-9. (Pubitemid 32249525)
19. Zelger B, Soyer HP., Between scylla and charybdis; mythology in dermatopathology. Dermatopathol, Pract Conceptual 2000; 6: 348-55.
20. Weedon D, Kerr JF., Atypical fibroxanthoma of skin: an electron microscope study. Pathology 1975; 7: 173-7.
21. Woyke S, Domagala W, Olszewski W, Korabiec M., Pseudosarcoma of the skin. an electron microscopic study and comparison with the fine structure of spindle-cell variant of squamous carcinoma. Cancer 1974; 33: 970-80.
22. Carson JW, Schwartz RA, McCandless CM Jr, French SW., Atypical fibroxanthoma of the skin report of a case with Langerhans-like granules. Arch Dermatol 1984; 120: 234-9. (Pubitemid 14188858)
23. Barr RJ, Wuerker RB, Graham JH., Ultrastructure of atypical fibroxanthoma. Cancer 1977; 40: 736-43. (Pubitemid 8177893)
24. Ricci A Jr, Cartun RW, Zakowski MF., Atypical fibroxanthoma: a study of 14 cases emphasizing the presence of Langerhans' histiocytes with implications for differential diagnosis by antibody panels. Am J Surg Pathol 1988; 12: 591-8.
25. Lee CS, Chou ST., P53 protein immunoreactivity in fibrohistiocytic tumors of the skin. Pathology 1998; 30: 272-5.
26. Youssef N, Vabres P, Buisson T, et al,. Two unusual tumors in a patient with xeroderma pigmentosum: atypical fibroxanthoma and basosquamous carcinoma. J Cutan Pathol 1999; 26: 430-5.
27. Dei Tos AP, Maestro R, Doglioni C, et al,. Ultraviolet-induced p53 mutations in atypical fibroxanthoma. Am J Pathol 1994; 145: 11-7. (Pubitemid 24217476)
28. Westermann FN, Langlois NE, Simpson JG., Apoptosis in atypical fibroxanthoma and pleomorphic malignant fibrous histiocytoma. Am J Dermatopathol 1997; 19: 228-31. (Pubitemid 27250881)
29. Sakamoto A, Oda Y, Itakura E, et al,. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma. Mod Pathol 2001; 14: 581-8. (Pubitemid 32554083)
30. Patterson JW, Jordan WP Jr., Atypical fibroxanthoma in a patient with xeroderma pigmentosum. Arch Dermatol 1987; 123: 1066-70. (Pubitemid 17134850)
31. Dilek FH, Akpolat N, Metin A, Ugras S., Atypical fibroxanthoma of the skin and the lower lip in xeroderma pigmentosum. Br J Dermatol 2000; 143: 618-20.
32. Soufir N, Ribojad M, Magnaldo T, et al,. Germline and somatic mutations of the INK4a-ARF gene in a xeroderma pigmentosum group C patient. J Invest Dermatol 2002; 119: 1355-60. (Pubitemid 36005620)
33. Evans HL, Smith JL., Spindle cell squamous carcinomas and sarcoma-like tumors of the skin: a comparative study of 38 cases. Cancer 1980; 45: 2687-97. (Pubitemid 10105329)
34. Jacobs DS, Edwards WD, Ye RC., Metastatic atypical fibroxanthoma of skin. Cancer 1975; 35: 457-63.
35. Hiscutt EL, Adams JR, Ryan JM, et al,. Atypical fibroxanthoma, lentigo maligna melanoma and squamous cell carcinoma arising in the site of a thermal burn treated with skin grafts. Br J Oral Maxillofac Surg 2009; 47: 157-8.
36. Ferri E, Iaderosa GA, Armato E., Atypical fibroxanthoma of the external ear in a cardiac transplant recipient: case report and the causal role of the immunosuppressive therapy. Auris Nasus Larynx 2008; 35: 260-3.
37. Kanitakis J, Euvrard S, Montazeri A, et al,. Atypical fibroxanthoma in a renal graft recipient. J Am Acad Dermatol 1996; 35 (2 Pt 1): 262-4.
38. Perrett CM, Cerio R, Proby CM, Harwood CA., Atypical fibroxanthoma in a renal transplant recipient. Histopathology 2005; 47: 326-7. (Pubitemid 41243273)
39. Paquet P, Pierard GE., Invasive atypical fibroxanthoma and eruptive actinic keratoses in a heart transplant patient. Dermatology 1996; 192: 411-3. (Pubitemid 26243993)
40. Hafner J, Kunzi W, Weinreich T., Malignant fibrous histiocytoma and atypical fibroxanthoma in renal transplant recipients. Dermatology 1999; 198: 29-32. (Pubitemid 29086331)
41. Lanigan S, Gilkes J., Spectrum of atypical fibroxanthoma of the skin. J R Soc Med 1984; 77 (Suppl 4): 27-30. (Pubitemid 15189479)
42. Stanton K, Wesson MC., Solitary nodule on the foot of a 37-year-old man. Arch Dermatol 1986; 122: 1327-8.
43. Davis JL, Randle HW, Zalla MJ, et al,. A comparison of Mohs micrographic surgery and wide excision for the treatment of atypical fibroxanthoma. Dermatol Surg 1997; 23: 105-10. (Pubitemid 27172880)
44. Weedon D., Tumors and tumor-like proliferations of fibrous and related tissues. In: Skin Pathology. 2nd edition. New York: Churchill Livingstone; 2002. p. 917-54.
45. Kim UR, Arora V, Shanti R, Shah AD., Neglected giant atypical fibroxanthoma of the eyelid. Ophthal Plast Reconstr Surg 2009; 25: 408-9.
46. Engelbrecht NE, Ford JG, White WL, Yeatts RP., Combined intraepithelial squamous neoplasia and atypical fibroxanthoma of the cornea and limbus. Am J Ophthalmol 2000; 129: 94-6. (Pubitemid 30026178)
47. Khong JJ, Muecke J., Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia. Br J Ophthalmol 2006; 90: 819-22. (Pubitemid 43973986)
48. Bugatti L, Filosa G., Dermatoscopic features of cutaneous atypical fibroxanthoma: three cases. Clin Exp Dermatol 2009; 34: e898-900.
49. Diaz-Cascajo C, Borghi S, Bonczkowitz M., Pigmented atypical fibroxanthoma. Histopathology 1998; 33: 537-41. (Pubitemid 28563379)
50. Diaz-Cascajo C, Weyers W, Borghi S., Pigmented atypical fibroxanthoma: a tumor that may be easily mistaken for malignant melanoma. Am J Dermatopathol 2003; 25: 1-5.
51. Wilsher MJ., Collision tumour: atypical fibroxanthoma and invasive melanoma. Pathology 2009; 41: 699-701.
52. Arsenovic N, Sen S, Naik V, et al,. Trichilemmal cyst with carcinoma in situ within an atypical fibroxanthoma. Am J Dermatopathol 2009; 31: 587-90.
53. Tronnier M, Vogelbruch M., Atypical fibroxanthoma arising in an area of syringocystadenoma papilliferum associated with nevus sebaceus: positivity of the atypical fibroxanthoma component for CD31. J Cutan Pathol 2007; 34 (Suppl 1): 58-63.
54. Rapini RP., Fibrohistiocytic proliferations and neoplasms. In:, Rapini RP, editor. Practical Dermatopathology. Mosby: Elsevier; 2005. p. 341-56.
55. Rios-Martin JJ, Delgado MD, Moreno-Ramirez D, et al,. Granular cell atypical fibroxanthoma: report of two cases. Am J Dermatopathol 2007; 29: 84-7.
56. Rudisaile SN, Hurt MA, Santa Cruz DJ., Granular cell atypical fibroxanthoma. J Cutan Pathol 2005; 32: 314-7. (Pubitemid 40459936)
57. Kim J, McNiff JM., Keloidal atypical fibroxanthoma: a case series. J Cutan Pathol 2009; 36: 535-9.
58. Patton A, Page R, Googe PB, King R., Myxoid atypical fibroxanthoma: a previously undescribed variant. J Cutan Pathol 2009; 36: 1177-84.
59. Khan ZM, Cockerell CJ., Atypical fibroxanthoma with osteoclast-like multinucleated giant cells. Am J Dermatopathol 1997; 19: 174-9. (Pubitemid 27184732)
60. Tomaszewski MM, Lupton GP., Atypical fibroxanthoma. An unusual variant with osteoclast-like giant cells. Am J Surg Pathol 1997; 21: 213-8. (Pubitemid 27084062)
61. Kemmerling R, Dietze O, Muller S, Neureiter D., Aspects of the differential diagnosis of clear-cell lesions of the skin in connection with the rare case of a clear-cell atypical fibroxanthoma. Pathol Res Pract 2009; 205: 365-70.
62. Requena L, Sangueza OP, Sanchez Yus E, Furio V., Clear-cell atypical fibroxanthoma: an uncommon histopathologic variant of atypical fibroxanthoma. J Cutan Pathol 1997; 24: 176-82.
63. Crowson AN, Carlson-Sweet K, Macinnis C, et al,. Clear cell atypical fibroxanthoma: a clinicopathologic study. J Cutan Pathol 2002; 29: 374-81.
64. Murali R, Palfreeman S., Clear cell atypical fibroxanthoma-report of a case with review of the literature. J Cutan Pathol 2006; 33: 343-8.
65. Stefanato CM, Robson A, Calonje JE., The histopathologic spectrum of regression in atypical fibroxanthoma. J Cutan Pathol 2010; 37: 310-5.
66. Chen KT., Atypical fibroxanthoma of the skin with osteoid production. Arch Dermatol 1980; 116: 113-4. (Pubitemid 10211862)
67. Dudelzak J, Sheehan DJ, Mullins SC, Peterson CM., Malignant perifollicular atypical fibroxanthoma treated with Mohs surgery. Dermatol Surg 2007; 33: 364-8. (Pubitemid 46328239)
68. Coindre JM., Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med 2006; 130: 1448-53.
69. Kuwano H, Hashimoto H, Enjoji M., Atypical fibroxanthoma distinguishable from spindle cell carcinoma in sarcoma-like skin lesions: a clinicopathologic and immunohistochemical study of 21 cases. Cancer 1985; 55: 172-80. (Pubitemid 15198216)
70. Kanner WA, Brill LB 2nd, Patterson JW, Wick MR., CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma. J Cutan Pathol 2010; 37: 744-50.
71. Hultgren TL, DiMaio DJ., Immunohistochemical staining of CD10 in atypical fibroxanthomas. J Cutan Pathol 2007; 34: 415-9. (Pubitemid 46633344)
72. de Feraudy S, Mar N, McCalmont TH., Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma. Am J Surg Pathol 2008; 32: 1111-22.
73. Monteagudo C, Calduch L, Navarro S, et al,. CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value. Am J Clin Pathol 2002; 117: 126-31.
74. Gleason BC, Calder KB, Cibull TL, et al,. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma. J Cutan Pathol 2009; 36: 543-7.
75. Dotto JE, Glusac EJ., P63 is a useful marker for cutaneous spindle cell squamous cell carcinoma. J Cutan Pathol 2006; 33: 413-7. (Pubitemid 43865299)
76. Morgan MB, Purohit C, Anglin TR., Immunohistochemical distinction of cutaneous spindle cell carcinoma. Am J Dermatopathol 2008; 30: 228-32.
77. Lazova R, Moynes R, May D, Scott G., LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma. Cancer 1997; 79: 2115-24. (Pubitemid 27227375)
78. Fish FS., Soft tissue sarcomas in dermatology. Dermatol Surg 1996; 22: 268-73. (Pubitemid 26088392)
79. Ly H, Selva D, James CL, Huilgol SC., Superficial malignant fibrous histiocytoma presenting as recurrent atypical fibroxanthoma. Australas J Dermatol 2004; 45: 106-9. (Pubitemid 38607923)
80. Leong AS, Milios J., Atypical fibroxanthoma of the skin: a clinicopathological and immunohistochemical study and a discussion of its histogenesis. Histopathology 1987; 11: 463-75.
81. Wylie J, Hampton N, Telfer MR, Clarke AM., Atypical fibroxanthoma: case series of 16 patients. Br J Oral Maxillofac Surg 2010; 48: 466-8.
82. Ma CK, Zarbo RJ, Gown AM., Immunohistochemical characterization of atypical fibroxanthoma and dermatofibrosarcoma protuberans. Am J Clin Pathol 1992; 97: 478-83.
83. Silvis NG, Swanson PE, Manivel JC, et al,. Spindle-cell and pleomorphic neoplasms of the skin. a clinicopathologic and immunohistochemical study of 30 cases, with emphasis on "atypical fibroxanthomas". Am J Dermatopathol 1988; 10: 9-19. (Pubitemid 18052887)
84. Smith KJ, Skelton HG III, Morgan AM, et al,. Spindle cell neoplasms coexpressing cytokeratin and vimentin (metaplastic squamous cell carcinoma). J Cutan Pathol 1992; 19: 286-93.
85. Heintz PW, White CR Jr., Diagnosis: atypical fibroxanthoma or not? Evaluating spindle cell malignancies on sun damaged skin: a practical approach. Semin Cutan Med Surg 1999; 18: 78-83.
86. Weedon D., Lentigines, nevi and melanomas. In:, Weedon D, editor. Skin Pathology. 2nd edition. New York: Churchill Livingstone; 2002. p. 803-58.
87. Sakamoto A, Oda Y, Yamamoto H, et al,. Calponin and h-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma. Virchows Arch 2002; 440: 404-9. (Pubitemid 34328073)
88. Longacre TA, Smoller BR, Rouse RV., Atypical fibroxanthoma. multiple immunohistologic profiles. Am J Surg Pathol 1993; 17: 1199-209. (Pubitemid 23344624)
89. Koch MB, Shih IM, Weiss SW, Folpe AL., Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics. Am J Surg Pathol 2001; 25: 58-64. (Pubitemid 32001833)
90. Smith-Zagone MJ, Prieto VG, Hayes RA, et al,. HMB-45 (gp103) and MART-1 expression within giant cells in an atypical fibroxanthoma: a case report. J Cutan Pathol 2004; 31: 284-6. (Pubitemid 38230574)
91. Winkelmann RK, Peters MS., Atypical fibroxanthoma. A study with antibody to S-100 protein. Arch Dermatol 1985; 121: 753-5. (Pubitemid 15051664)
92. Clarke LE, Frauenhoffer E, Fox E, et al,. CD10-positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthoma. J Cutan Pathol 2010; 37: 737-43.
93. Kanitakis J, Bourchany D, Claudy A., Expression of the CD10 antigen (neutral endopeptidase) by mesenchymal tumors of the skin. Anticancer Res 2000; 20: 3539-44.
94. Jensen K, Wilkinson B, Wines N, Kossard S., Procollagen 1 expression in atypical fibroxanthoma and other tumors. J Cutan Pathol 2004; 31: 57-61. (Pubitemid 38130277)
95. Rapini RP., Special stains. In: Practical Dermatopathology. Mosby: Elsevier; 2005. p. 373-7.
96. Hartel PH, Jackson J, Ducatman BS, Zhang P., CD99 immunoreactivity in atypical fibroxanthoma and pleomorphic malignant fibrous histiocytoma: a useful diagnostic marker. J Cutan Pathol 2006; 33 (Suppl 2): 24-8. (Pubitemid 44370073)
97. Mathew RA, Schlauder SM, Calder KB, Morgan MB., CD117 immunoreactivity in atypical fibroxanthoma. Am J Dermatopathol 2008; 30: 34-6. (Pubitemid 351161628)
98. Beer TW., CD117 in atypical fibroxanthoma: tumor or stroma? Am J Dermatopathol 2008; 30: 401-2.
99. Barr KL, Russo JJ, Vincek V., Re: CD117 immunoreactivity in atypical fibroxanthoma. Am J Dermatopathol 2009; 31: 96-8.
100. Beer TW, Haig D., CD117 is not a useful marker for diagnosing atypical fibroxanthoma. Am J Dermatopathol 2009; 31: 649-52.
101. Pouryazdanparast P, Yu L, Cutlan JE, et al,. Diagnostic value of CD163 in cutaneous spindle cell lesions. J Cutan Pathol 2009; 36: 859-64.
102. Oshiro Y, Fukuda T, Tsuneyoshi M., Atypical fibroxanthoma versus benign and malignant fibrous histiocytoma: a comparative study of their proliferative activity using MIB-1, DNA flow cytometry, and p53 immunostaining. Cancer 1995; 75: 1128-34.
103. Hanly AJ, Jorda M, Elgart GW, et al,. High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors. Arch Pathol Lab Med 2006; 130: 831-4.
104. Zalla MJ, Randle HW, Brodland DG, et al,. Mohs surgery vs wide excision for atypical fibroxanthoma: follow-up. Dermatol Surg 1997; 23: 1223-4.
105. Cai JP, Randall B., HMB-45 expression in a clear cell variant of atypical fibroxanthoma. J Cutan Pathol 2006; 33: 186-8.
106. Dahl I., Atypical fibroxanthoma of the skin: a clinico-pathological study of 57 cases. Acta Pathol Microbiol Scand A 1976; 84: 183-97.
107. Koch M, Dimmler A, Alexiou C., Recurrent and metastasizing atypical fibroxanthoma. HNO 2008; 56: 1046-51.
108. Muenster MR, Hoang MP., Left facial mass in an elderly man metastasizing atypical fibroxanthoma of the skin. Arch Pathol Lab Med 2006; 130: 735-6.
109. Lum DJ, King AR., Peritoneal metastases from an atypical fibroxanthoma. Am J Surg Pathol 2006; 30: 1041-6. (Pubitemid 44264956)
110. Giuffrida TJ, Kligora CJ, Goldstein GD., Localized cutaneous metastases from an atypical fibroxanthoma. Dermatol Surg 2004; 30 (12 Pt 2): 1561-4. (Pubitemid 40053527)
111. Grosso M, Lentini M, Carrozza G, Catalano A., Metastatic atypical fibroxanthoma of skin. Pathol Res Pract 1987; 182: 443-7.
112. Kargi E, Gungor E, Verdi M, et al,. Atypical fibroxanthoma and metastasis to the lung. Plast Reconstr Surg 2003; 111: 1760-2.
113. Sankar NM, Pang KS, Thiruchelvam T, Meldrum-Hanna WG., Metastasis from atypical fibroxanthoma of skin. Med J Aust 1998; 168: 418-9.
114. Glavin FL, Cornwell ML., Atypical fibroxanthoma of the skin metastatic to a lung: report of a case, features by conventional and electron microscopy, and a review of relevant literature. Am J Dermatopathol 1985; 7: 57-63. (Pubitemid 15135293)
115. Michie BA, Reid RP, Fallowfield ME., Aneuploidy in atypical fibroxanthoma: DNA content quantification of 10 cases by image analysis. J Cutan Pathol 1994; 21: 404-7.
116. Mihic-Probst D, Zhao J, Saremaslani P, et al,. CGH analysis shows genetic similarities and differences in atypical fibroxanthoma and undifferentiated high grade pleomorphic sarcoma. Anticancer Res 2004; 24: 19-26. (Pubitemid 38279684)
117. Worrell JT, Ansari MQ, Ansari SJ, Cockerell CJ., Atypical fibroxanthoma: DNA ploidy analysis of 14 cases with possible histogenetic implications. J Cutan Pathol 1993; 20: 211-5.
118. Sakamoto A, Oda Y, Itakura E, et al,. H-, K-, and N-ras gene mutation in atypical fibroxanthoma and malignant fibrous histiocytoma. Hum Pathol 2001; 32: 1225-31. (Pubitemid 33104434)
119. Gonzalez-Garcia R, Nam-Cha SH, Munoz-Guerra MF, et al,. Atypical fibroxanthoma of the head and neck: report of 5 cases. J Oral Maxillofac Surg 2007; 65: 526-31.
120. Jacoby WD., Cryosurgical treatment of recurrent atypical fibroxanthoma of the skin. Preliminary report. Cutis 1978; 22: 599-601.
121. Clayton BD, Leshin B, Hitchcock MG, et al,. Utility of rush paraffin-embedded tangential sections in the management of cutaneous neoplasms. Dermatol Surg 2000; 26: 671-8. (Pubitemid 30470633)
122. Hafner J, Schutz K, Morgenthaler W, et al,. Micrographic surgery ('slow Mohs') in cutaneous sarcomas. Dermatology 1999; 198: 37-43. (Pubitemid 29086333)
123. Brown MD, Swanson NA., Treatment of malignant fibrous histiocytoma and atypical fibrous xanthomas with micrographic surgery. J Dermatol Surg Oncol 1989; 15: 1287-92. (Pubitemid 20027169)